
The impact of climate change on neurological diseases
In this episode, we bring you a discussion recorded at EAN 2026 exploring the growing impact of climate change on neurological health. The panel discusses evidence linking rising temperatures and envi...
28 Sep 13min

Advancing the treatment of myasthenia gravis: current and emerging therapies
Welcome to this episode of the VJNeurology Podcast, where leading experts will explore some of the latest advances in the treatment of myasthenia gravis, discussing emerging therapeutic strategies and...
18 Sep 21min

Life after Stroke: Practical strategies for secondary prevention and rehabilitation
Episode 2 of our Life after Stroke roundtable discussion series is now available as a podcast! In this exclusive discussion, leading experts Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton...
11 Sep 1h 11min

Orexin agonists in narcolepsy: current evidence and future directions
In this episode of the VJNeurology Podcast, we explore the rapidly evolving landscape of orexin agonists for the treatment of narcolepsy. Following the recent FDA approval of oveporexton, as well as n...
4 Sep 20min

Life after Stroke: First steps in secondary stroke prevention
Episode 1 of our Life after Stroke roundtable discussion series is now available as a podcast! In this exclusive discussion, leading experts Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton...
28 Aug 55min

Advances in sleep medicine and research from SLEEP 2026
This episode of the VJNeurology Podcast showcases advances across insomnia, restless legs syndrome, narcolepsy, and sleep apnea from SLEEP 2026. Leading experts discuss updates to the American Academy...
10 Jul 41min

AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!
This episode of the VJNeurology Podcast showcases key trial updates from the American Academy of Neurology Annual Meeting in Chicago, IL. Highlights include orexin receptor agonists for narcolepsy, AM...
5 Mai 32min



















